HHS Secretary Robert F. Kennedy Jr. paused a clinical trial funded by the Biomedical Advanced Research and Development Authority (BARDA) for a COVID-19 oral vaccine made by Vaxart. Kennedy said, “While it is crucial that the Department [of] Health and Human Services (HHS) support pandemic preparedness, four years of the Biden administration’s failed oversight have made it necessary to review agreements for vaccine production, including Vaxart’s. I look forward to working with Vaxart and medical experts to ensure this work produces safe, effective, and fiscal-minded vaccine technology.”

There is currently a 90-day pause on the trial that was set to begin on Monday with 10,000 clinical trial participants. The oral vaccine would be evaluated against the existing mRNA COVID-19 vaccines currently available under Emergency Use Authorization (EUA).

Kennedy was named the chair of the new Make America Health Again (MAHA) commission, created by an executive order signed by President Donald Trump just after Kennedy was confirmed as HHS secretary.

The executive order states, “It shall be the policy of the Federal Government to aggressively combat the critical health challenges facing our citizens, including the rising rates of mental health disorders, obesity, diabetes, and other chronic diseases.  To do so, executive departments and agencies (agencies) that address health or healthcare must focus on reversing chronic disease.”

The commission will work to provide transparent “open-source” data to the American people. This includes funding “gold-standard” research through the NIH and ensuring that the “United States food is the healthiest, most abundant, and most affordable in the world.”

In October, Kennedy said “If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags.” According to recent reports, firings have begun within HHS.

Earlier this week, the conflict of interest discussion ramped up when Patrizia Cavazzoni was hired as chief medical officer for Pfizer about a month after leaving her position with the FDA. She joined the FDA in 2018 and became the director of the FDA’s Center for Drug Evaluation and Research (CDER) in 2021. She resigned from the position in January, shortly before Donald Trump was sworn in as the 47th president of the United States.

The Pfizer press release states, “Before joining CDER, Dr. Cavazzoni held several senior executive positions in the pharmaceutical industry for nearly two decades, including at Pfizer, Eli Lilly, and Sanofi. During her prior tenure at Pfizer, Dr. Cavazzoni led clinical sciences and development operations for the company across multiple senior roles.”

Pfizer received full EUA approval for its COVID-19 vaccine in August 2021 while Cavazzoni was the director of CDER within the FDA. The Daily Mail reported that Cavazzoni’s new role with Pfizer could pay up to $500,000 per year before bonuses, according to job posting sites.

Kennedy has promised to root out conflicts of interest, and the latest move by Cavazzoni reflects the ongoing revolving door between big pharmaceutical companies and federal health agencies.

During Kennedy’s address to HHS staff, he said, “I’m not going to come in here and impose my belief over any of yours. Instead, we’re going to work together to launch a new era of radical transparency. We will convene representatives of all viewpoints to study the causes for the drastic rise in chronic disease. Some of the possible factors we will investigate were formerly taboo or insufficiently scrutinized: the childhood vaccine schedule, electromagnetic radiation, glyphosate, other pesticides, ultra-processed foods, artificial food additives, SSRIs and other psychiatric drugs, PFAS, PFOAs, microplastics—nothing is going to be off limits. Whatever belief or suspicion I have expressed in the past, I’m willing to subject them all to the scrutiny of unbiased science.”

Kennedy also halted the CDC’s “wild to mild” flu vaccination marketing program that has been running since 2023. Reports say Kennedy wants future vaccine ads to focus on “informed consent.” In this case, the ads would mention the risks and benefits of getting the flu vaccine.

Yesterday on The HighWire, Jefferey Jaxen reported on the halt to the flu vaccination campaign. He presented a 2012 study that shows risks associated with flu vaccinations that could potentially be mentioned in future ads if they focus on informed consent. A randomized placebo study with 115 children found those who received the trivalent inactivated influenza vaccine were 440% more likely to be infected with “virologically-confirmed non-influenza” or upper respiratory infections.

The flu vaccination ad program attempted to show the public that flu vaccinations can prevent severe outcomes from infection and don’t necessarily prevent transmission. The ads did not provide the information that the vaccines can increase the likelihood of infection with other non-flu illnesses. Running ads that focus on informed consent could include both of these messages so individuals can make an informed decision with their doctors.

Shirin A. Mazumder, MD, an infectious disease expert in Memphis, Tennessee, said, “A shift in the messaging away from the benefit of vaccines has the potential to affect public perception and lead to an increase in vaccine-preventable illnesses and deaths in a population where vaccine uptake for flu and other respiratory viruses is already low.”

Jeff Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases (NFID) said the current flu season is the “most severe” since 2017-2018.

The flu season peak typically ends in late February, with most people receiving their flu vaccinations in September or October, before the season officially begins. Medscape reported, “Many clinicians already discuss issues related to informed consent before administering any vaccines, Mazumder said.”

It is not possible to know how many clinicians provide informed consent before administering a vaccine, and it is not possible to know the specific details they provide.

Kennedy promised radical transparency as the HHS secretary, which involved presenting all of the science for the public to make informed decisions. It has not yet been reported if the “wild to mild” flu vaccine campaign will continue this season with a balanced description of the risks and benefits of taking the vaccine.

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

A new fluoride study has been criticized for being a tool of the industry to promote continued water fluoridation following the banning of the practice in Utah and Florida. The authors conducted a simulation model and cost-effectiveness analysis with data from 8484 children with a mean age of 9.6 years. The authors concluded eliminating fluorideContinue reading New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

More news about Health & Nutrition

Vaccines

HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

HHS has terminated a $766 million contract with Moderna to develop an mRNA bird flu vaccine. HHS spokesman Andrew Nixon said the decision is about “safety, integrity, and trust.” He added that “mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimateContinue reading HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

More news about Vaccines

Science & Tech

Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

A viral video released from an undisclosed Chinese factory shows a humanoid robot malfunctioning and attacking the factory workers. The Unitree H1, a product of the Chinese company Unitree Robotics, can be seen flailing its arms as workers move away to protect themselves. The robot was hung on a crane, and the workers were notContinue reading Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

More news about Science & Tech

Environment

CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

Newsnation reported this week that the CDC advised local health care providers in East Palestine, OH, not to test local residents for chemical illnesses after the town was exposed to a toxic plume from a “controlled burn” after the Norfolk Southern train derailment in 2023. A lawsuit has been filed against Norfolk Southern and moreContinue reading CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

More news about Environment

Policy

HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

HHS Secretary Robert F. Kennedy Jr. wrote a letter addressed to healthcare providers saying he expects them to update their “treatment protocols and training to ensure that care for children with gender dysphoria is evidence-based.” The letter was also addressed to healthcare risk managers and state medical boards. The letter refers to the report publishedContinue reading HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

More news about Policy